{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T21:14:07Z","timestamp":1778188447053,"version":"3.51.4"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background: <\/jats:bold>Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD\u2013MBD is very important in the clinic. In China, Fucoidan (FPS), a natural compound of <jats:italic>Laminaria japonica<\/jats:italic> has been frequently used to improve renal dysfunction in CKD. However, it remains elusive whether FPS can ameliorate CKD\u2013MBD. FGF23-Klotho signaling axis is reported to be useful for regulating mineral and bone metabolic disorder in CKD\u2013MBD. This study thereby aimed to clarify therapeutic effects of FPS in the CKD\u2013MBD model rats and its underlying mechanisms <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>, compared to Calcitriol (CTR).<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold>All male rats were divided into four groups: Sham, CKD\u2013MBD, FPS and CTR. The CKD\u2013MBD rat models were induced by adenine administration and uninephrectomy, and received either FPS or CTR or vehicle after induction of renal injury for 21\u00a0days. The changes in parameters related to renal dysfunction and renal tubulointerstitial damage, calcium-phosphorus metabolic disorder and bone lesion were analyzed, respectively. Furthermore, at sacrifice, the kidneys and bone were isolated for histomorphometry, immunohistochemistry and Western blot. <jats:italic>In vitro<\/jats:italic>, the murine NRK-52E cells were used to investigate regulative actions of FPS or CTR on FGF23-Klotho signaling axis, ERK1\/2-SGK1-NHERF-1-NaPi-2a pathway and Klotho deficiency.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold>Using the modified CKD\u2013MBD rat model and the cultured NRK-52E cells, we indicated that FPS and CTR alleviated renal dysfunction and renal tubulointerstitial damage, improved calcium-phosphorus metabolic disorder and bone lesion, and regulated FGF23-Klotho signaling axis and ERK1\/2-SGK1-NHERF-1-NaPi-2a pathway in the kidney. In addition, using the shRNA-Klotho plasmid-transfected cells, we also detected, FPS accurately activated ERK1\/2-SGK1-NHERF-1-NaPi-2a pathway through Klotho loss reversal.<\/jats:p><jats:p><jats:bold>Conclusion: <\/jats:bold>In this study, we emphatically demonstrated that FPS, a natural anti-renal dysfunction drug, similar to CTR, improves renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD\u2013MBD model rats. More importantly, we firstly found that beneficial effects <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> of FPS on phosphorus reabsorption are closely associated with regulation of FGF23-Klotho signaling axis and ERK1\/2-SGK1-NHERF-1-NaPi-2a pathway in the kidney. This study provided pharmacological evidences that FPS directly contributes to the treatment of CKD\u2013MBD.<\/jats:p>","DOI":"10.3389\/fphar.2020.586725","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T15:54:58Z","timestamp":1611849298000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD\u2013MBD Model Rats by Targeting FGF23-Klotho Signaling Axis"],"prefix":"10.3389","volume":"11","author":[{"given":"Bu-Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fee-Lan","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can-Can","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yue","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Gang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/imj.14129","article-title":"Bone health in chronic kidney disease-mineral and bone disorder: a clinical case seminar and update","volume":"48","author":"Aleksova","year":"2018","journal-title":"Intern. Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"6604","DOI":"10.1074\/jbc.M109.056044","article-title":"WNK4 kinase stimulates caveola-mediated endocytosis of TRPV5 amplifying the dynamic range of regulation of the channel by protein kinase C","volume":"285","author":"Cha","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"C159","DOI":"10.1152\/ajpcell.00456.2004","article-title":"Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+\/H+ exchanger regulatory factor-1 complexes","volume":"289","author":"D\u00e9liot","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bone.2016.09.010","article-title":"FGF23-Klotho signaling axis in the kidney","volume":"100","author":"Erben","year":"2017","journal-title":"Bone"},{"key":"B6","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.3390\/md13095920","article-title":"Therapies from fucoidan: an update","volume":"13","author":"Fitton","year":"2015","journal-title":"Mar. Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.phymed.2018.12.021","article-title":"Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4\/NF-\u03baB signaling","volume":"57","author":"Han","year":"2019","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000477244","article-title":"Hope for CKD-MBD patients: new diagnostic approaches for better treatment of CKD-MBD","volume":"3","author":"Hocher","year":"2017","journal-title":"Kidney Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease-mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10616-015-9894-5","article-title":"The in vitro and in vivo effects of the low molecular weight fucoidan on the bone osteogenic differentiation properties","volume":"68","author":"Hwang","year":"2016","journal-title":"Cytotechnology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"31759","DOI":"10.1038\/srep31759","article-title":"Low molecular weight fucoidan protects renal tubular cells from injury induced by albumin overload","volume":"6","author":"Jia","year":"2016","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3892\/mmr.2016.6062","article-title":"Low\u2011molecular weight fucoidan inhibits the differentiation of osteoclasts and reduces osteoporosis in ovariectomized rats","volume":"15","author":"Jin","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbrc.2008.08.010","article-title":"WNK4 regulates the secretory pathway via which TRPV5 is targeted to the plasma membrane","volume":"75","author":"Jiang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"F545","DOI":"10.1152\/ajprenal.00187.2006","article-title":"WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4","volume":"292","author":"Jiang","year":"2007","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic Kidney Disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s10157-016-1357-6","article-title":"The FGF23 and Klotho system beyond mineral metabolism","volume":"21","author":"Kuro-O","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.ki.5000169","article-title":"Coordinated control of renal Ca2+ handling","volume":"69","author":"Lambers","year":"2006","journal-title":"Kidney Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/ki.1992.165","article-title":"Estimation of glomerular volume: a comparison of four methods","volume":"41","author":"Lane","year":"1992","journal-title":"Kidney Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/mnh.0000000000000053","article-title":"Renal phosphate transporters","volume":"23","author":"Lederer","year":"2014","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11033-016-3971-5","article-title":"Calcitriol regulates angiotensin-converting enzyme and angiotensin converting-enzyme 2 in diabetic kidney disease","volume":"43","author":"Lin","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.18632\/aging.101723","article-title":"Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy","volume":"10","author":"Liu","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"B20","first-page":"1980","article-title":"Shenkang injection, a modern preparation of Chinese patent medicine, diminishes tubulointerstitial fibrosis in obstructive nephropathy via targeting pericyte-myofibroblast transition","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000500053","article-title":"Executive summary: clinical practice guideline of chronic kidney disease-mineral and bone disorder (CKD-MBD) in China","volume":"5","author":"Liu","year":"2019","journal-title":"Kidney Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopha.2018.06.092","article-title":"The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor","volume":"106","author":"Ma","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/bf02010747","article-title":"The effect of electric fields on osteoporosis of disuse","volume":"25","author":"Martin","year":"1978","journal-title":"Calcif. Tissue Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/hypertensionaha.107.103788","article-title":"WNK kinases and renal sodium transport in health and disease: an integrated view","volume":"51","author":"McCormick","year":"2008","journal-title":"Hypertension."},{"key":"B25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1210\/er.2004-0002","article-title":"Noncalcemic actions of vitamin D receptor ligands","volume":"26","author":"Nagpal","year":"2005","journal-title":"Endocr. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","volume":"94","author":"Neven","year":"2018","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.semnephrol.2014.09.005","article-title":"New insights into the FGF23-Klotho axis","volume":"34","author":"Olauson","year":"2014","journal-title":"Semin. Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1159\/000326903","article-title":"Vitamin D and vascular calcification in chronic kidney disease","volume":"34","author":"Rodriguez","year":"2011","journal-title":"Kidney Blood Press. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e86301","DOI":"10.1371\/journal.pone.0086301","article-title":"Reduced renal \u03b1-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism","volume":"9","author":"Sakan","year":"2014","journal-title":"PLoS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: a review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am. J. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"43790","DOI":"10.1038\/srep43790","article-title":"Rhein inhibits autophagy in rat renal tubular cells by regulation of AMPK\/mTOR signaling","volume":"7","author":"Tu","year":"2017","journal-title":"Sci. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/md17010032","article-title":"Fucoidan structure and activity in relation to anti-cancer mechanisms","volume":"17","author":"Van Weelden","year":"2019","journal-title":"Mar. Drugs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/bs.pmbts.2019.03.011","article-title":"Use of fucoidan to treat renal diseases: a review of 15 years of clinic studies","volume":"163","author":"Wang","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.5551\/jat.40170","article-title":"Newly developed rat model of chronic kidney disease-mineral bone disorder","volume":"25","author":"Watanabe","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"key":"B38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/ijnrd.S191156","article-title":"Chronic kidney disease-mineral and bone disorder (CKD-MBD): current perspectives","volume":"12","author":"Waziri","year":"2019","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3389\/fphar.2018.00443","article-title":"Inhibition of Akt\/mTOR\/p70S6K signaling activity with Huangkui capsule alleviates the early glomerular pathological changes in diabetic nephropathy","volume":"9","author":"Wu","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1055\/s-2003-40634","article-title":"Effects of fucoidan on chronic renal failure in rats","volume":"69","author":"Zhang","year":"2003","journal-title":"Planta Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.kint.2016.07.040","article-title":"Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease","volume":"91","author":"Zhang","year":"2017","journal-title":"Kidney Int."}],"updated-by":[{"DOI":"10.3389\/fphar.2024.1446609","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.586725\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:58:25Z","timestamp":1721725105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.586725\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":42,"alternative-id":["10.3389\/fphar.2020.586725"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.586725","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fphar.2024.1446609","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"article-number":"586725"}}